[Detection of a neuroendocrine differentiated cystic pancreatic lesion by gallium-68-DOTATOC-PET/CT with inconclusive MRI, CT and ultrasound diagnosis].
Fröling
V
V
Denecke
T
T
Pöllinger
A
A
Schreiter
N F
NF
D014408:Biomarkers, Tumor / Q000032:analysis; D002864:Chromogranins / Q000032:analysis; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D015282:Octreotide / Q000031:analogs & derivatives*; D009942:Organometallic Compounds; D010181:Pancreatic Cyst / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D049268:Positron-Emission Tomography; D017481:Receptors, Somatostatin / Q000032:analysis; D016708:Synaptophysin / Q000032:analysis; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
D014408:Biomarkers, Tumor; D002864:Chromogranins; C499142:Ga(III)-DOTATOC; D009942:Organometallic Compounds; D017481:Receptors, Somatostatin; D016708:Synaptophysin; D015282:Octreotide